Skip to main content
SpringerLink
Log in

Surgical Approach to Cutaneous Malignancy with Systemic Implications

  • Chapter
  • First Online:
Dermato-Oncology Study Guide

  • 320 Accesses

Abstract

Surgical procedures remain key diagnostic and therapeutic steps in the proper diagnosis and management of cutaneous malignancy. This chapter reviews surgical considerations necessary for optimizing the surgical approach to cutaneous malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ADPA:

Aggressive digital papillary adenocarcinoma

AUC:

Appropriate use criteria

BCC:

Basal cell carcinoma

CLL:

Chronic lymphocytic leukemia

CNB:

Core needle biopsy

cSCC:

Cutaneous squamous cell carcinoma

CT:

Computed tomography

DFSP:

Dermatofibrosarcoma protuberans

ED&C:

Electrodesiccation and curettage

EMPD:

Extramammary paget’s disease

EPC:

Eccrine porocarcinoma

FNA:

Fine needle aspiration

HPV:

Human papillomavirus

IHC:

Immunohistochemical

LM:

Lentigo maligna

LN:

Lymph node

MCC:

Merkel cell carcinoma

MMS:

Mohs micrographic surgery

MRI:

Magnetic resonance imaging

NMSC:

Non-melanoma skin cancer

PET:

Positron emission tomography

PNI:

Perineural invasion

RT:

Radiotherapy

SCC:

Squamous cell carcinoma

SLNB:

Sentinel lymph node biopsy

US:

Ultrasonography

UVA:

Ultraviolet A radiation

UVB:

Ultraviolet B radiation

VEGF:

Vascular endothelial growth factor

WLE:

Wide local excision

References

  1. Ad Hoc Task Force, Connolly SM, Baker DR, Coldiron BM, Fazio MJ, Storrs PA, Vidimos AT, Zalla MJ, Brewer JD, Smith Begolka W, Ratings Panel, Berger TG, Bigby M, Bolognia JL, Brodland DG, Collins S, Cronin TA Jr, Dahl MV, Grant-Kels JM, Hanke CW, Hruza GJ, James WD, Lober CW, EI MB, Norton SA, Roenigk RK, Wheeland RG, Wisco OJ. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. J Am Acad Dermatol. 2012;67(4):531–50.

    Article  Google Scholar 

  2. American Medical Association. Mohs micrographic surgery. CPT Assist. 2006;16:1–7. Google Scholar.

    Google Scholar 

  3. Bolognia J, Jorizzo J, Schaffer JV. Dermatology. 2nd ed. Philadelphia: Elsevier Saunders; 2012.

    Google Scholar 

  4. Kalra A, Prucher GM, Hodges S. The role of core needle biopsies in the management of neck lumps. Ann R Coll Surg Engl. 2019;101:193–6.

    Article  PubMed  CAS  Google Scholar 

  5. Kocjan G. Fine needle aspiration cytology: diagnostic principles and dilemmas. 1st ed. Berlin: Springer; 2006.

    Google Scholar 

  6. Lin F, Liu H, Zhang J, Kremitske D. Handbook of practical fine needle aspiration and small tissue biopsies. 1st ed. Heidelberg: Springer; 2017.

    Google Scholar 

  7. Mendese G, Maloney M, Bordeaux J. To scoop or not to scoop: the diagnostic and therapeutic utility of the scoop-shave biopsy for pigmented lesions. Dermatol Surg. 2014;40(10):1077–83.

    Article  PubMed  CAS  Google Scholar 

  8. Özel D, Aydın T. A clinical compilation of lymph node pathologies comparing the diagnostic performance of biopsy methods. J Ultrasound. 2019;22(1):59–64.

    Article  PubMed  Google Scholar 

  9. Pickett H. Shave and punch biopsy for skin lesions. Am Fam Physician. 2011;84(9):995–1002.

    PubMed  Google Scholar 

  10. Amin MB, Edge SB, Greene FL, et al., editors. AJCC cancer staging manual. 8th ed. New York: Springer; 2017.

    Google Scholar 

  11. Austin E, Mamalis A, Ho D, Jagdeo J. Laser and light-based therapy for cutaneous and soft-tissue metastases of malignant melanoma: a systematic review. Arch Dermatol Res. 2017;309(4):229–42.

    Article  PubMed  Google Scholar 

  12. Braun RP, Rabinovitz HS, Oliviero M, Kopf AW, Saurat JH. Dermoscopy of pigmented skin lesions. J Am Acad Dermatol. 2005;52:109–21.

    Article  PubMed  Google Scholar 

  13. Campos de Castro BA, JCS F, Pedrosa MS, Raquel de Almeida Marques D, Gonçalves VP, JMM P. Surg Cosmet Dermatol. 2015;7(1):65–7.

    Google Scholar 

  14. Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, Lazar AJ, Faries MB, Kirkwood JM, McArthur GA, Haydu LE, Eggermont AMM, Flaherty KT, Balch CM, Thompson JF, for members of the American Joint Committee on Cancer Melanoma Expert Panel and the International Melanoma Database and Discovery Platform. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(6):472–92.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hayes AJ, Maynard L, Coombes G, et al. Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial. Lancet Oncol. 2016;17:184–92. Higgins HW 2nd, Lee KC, Galan A, Leffell DJ.Melanoma in situ: Part II. Histopathology, treatment, and clinical management.J Am Acad Dermatol. 2015 Aug;73(2):193–203.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Hunger RE, Angermeier S, Seyed Jafari SM, Ochsenbein A, Shafighi M. A retrospective study of 1- versus 2-cm excision margins for cutaneous malignant melanomas thicker than 2 mm. J Am Acad Dermatol. 2015;72:1054–9.

    Article  PubMed  Google Scholar 

  17. Kunishige JH, Brodland DG, Zitelli JA. Surgical margins for melanoma in situ: When 5-mm margins are really 9 mm. J Am Acad Dermatol. 2015;72(4):745.

    Article  PubMed  Google Scholar 

  18. Kasprzak JM, Xu Y. Diagnosis and management of lentigo maligna: a review. Drugs Context. 2015;4:212–81.

    Article  Google Scholar 

  19. Paraskevas LR, Halpern AC, Marghoob AA. Utility of the Wood's light: five cases from a pigmented lesion clinic. Br J Dermatol. 2005;152(5):1039–44.

    Article  PubMed  Google Scholar 

  20. Robinson JK. Margin control for lentigo maligna. J Am Acad Dermatol. 1994;31:79–85.

    Article  PubMed  CAS  Google Scholar 

  21. Sladden MJ, Balch C, Barzilai DA, Berg D, Freiman A, Handiside T, Hollis S, Lens MB, Thompson JF. Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev. 2009;4:CD004835.

    Google Scholar 

  22. Swanson NA, Lee KK, Gorman A, Lee HN. Biopsy techniques. Diagnosis of melanoma. Dermatol Clin. 2002;20:677–80.

    Article  PubMed  Google Scholar 

  23. Thomas JM, Newton-Bishop J, A'Hern R, Coombes G, Timmons M, Evans J, Cook M, Theaker J, Fallowfield M, O'Neill T, Ruka W, Bliss JM, United Kingdom Melanoma Study Group; British Association of Plastic Surgeons; Scottish Cancer Therapy Network. Excision margins in high-risk malignant melanoma. N Engl J Med. 2004;350(8):757–66.

    Article  PubMed  CAS  Google Scholar 

  24. Veronesi U, Cascinelli N, Adamus J, Balch C, Bandiera D, Barchuk A, Bufalino R, Craig P, De Marsillac J, Durand JC, et al. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. N Engl J Med. 1988;318(18):1159–62.

    Article  PubMed  CAS  Google Scholar 

  25. Delgado Jiménez Y, Camarero-Mulas C, Sanmartín-Jiménez O, et al. Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma. Int J Dermatol. 2018;57(11):1375–81.

    Article  PubMed  Google Scholar 

  26. Jennings L, Schmults CD. Management of high-risk cutaneous squamous cell carcinoma. J Clin Aesthet Dermatol. 2010;3(4):39–48.

    PubMed  PubMed Central  Google Scholar 

  27. Karia PS, Jambusaria-Pahlajani A, Harrington DP, et al. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women’s Hospital tumor staging for cutaneous squamous cell carcinoma. J Clin Oncol. 2014;32(4):327–34.

    Article  PubMed  Google Scholar 

  28. Mikhail GR, Mohs FE. Mohs micrographic surgery. Philadelphia: W.B. Saunders; 1991. p. 7–13.

    Google Scholar 

  29. Mierzwa ML. Radiotherapy for skin cancers of the face, head, and neck. Facial Plast Surg Clin North Am. 2019;27(1):131–8.

    Article  PubMed  Google Scholar 

  30. Motaparthi K, Kapil JP, Velazquez EF. Cutaneous squamous cell carcinoma: review of the eighth edition of the American Joint Committee on Cancer Staging Guidelines, prognostic factors, and histopathologic variants. Adv Anat Pathol. 2017;24(4):171–94.

    Article  PubMed  Google Scholar 

  31. Reschly MJ, Shenefelt PD. Controversies in skin surgery: electrodessication and curettage versus excision for low-risk, small, well-differentiated squamous cell carcinomas. J Drugs Dermatol. 2010;9(7):773–6.

    PubMed  Google Scholar 

  32. Seth R, Revenaugh PC, Vidimos AT, Scharpf J, Somani AK, Fritz MA. Simultaneous intraoperative Mohs clearance and reconstruction for advanced cutaneous malignancies. Arch Facial Plast Surg. 2011;13(6):404–10.

    Article  PubMed  Google Scholar 

  33. Vance KK, Pytynia KB, Antony AK, Krunic AL. Mohs moat: peripheral cutaneous margin clearance in a collaborative approach for aggressive and deeply invasive basal cell carcinoma. Australas J Dermatol. 2014;55(3):198–200.

    Article  PubMed  Google Scholar 

  34. Wiznia LE, Federman DG. Treatment of basal cell carcinoma in the elderly: what nondermatologists need to know. Am J Med. 2016;129(7):655–60.

    Article  PubMed  Google Scholar 

  35. Femia D, Prinzi N, Anichini A, et al. Treatment of advanced merkel cell carcinoma: current therapeutic options and novel immunotherapy approaches. Target Oncol. 2018;13:567.

    Article  PubMed  Google Scholar 

  36. Kline L, Coldiron B. Mohs micrographic surgery for the treatment of merkel cell carcinoma. Dermatol Surg. 2016;42(8):945–51.

    Article  PubMed  CAS  Google Scholar 

  37. Singh B, Qureshi MM, Truong MT, Sahni D. Demographics and outcomes of stage I and II Merkel cell carcinoma treated with Mohs micrographic surgery compared with wide local excision in the National Cancer Database. J Am Acad Dermatol. 2018;79(1):126–134.e3.

    Article  PubMed  Google Scholar 

  38. Tai P. A practical update of surgical management of merkel cell carcinoma of the skin. ISRN Surg. 2013;2013:850797.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Tello TL, Coggshall K, Yom SS, Yu SS. Merkel cell carcinoma: an update and review: current and future therapy. J Am Acad Dermatol. 2018;78(3):445–54.

    Article  PubMed  Google Scholar 

  40. Bogucki B, Neuhaus I, Hurst EA. Dermatofibrosarcoma protuberans: a review of the literature. Dermatol Surg. 2012;38:537–51.

    Article  PubMed  CAS  Google Scholar 

  41. Criscito MC, Martires KJ, Stein JA. Prognostic factors, treatment, and survival in dermatofibrosarcoma protuberans. JAMA Dermatol. 2016;152(12):1365–71.

    Article  PubMed  Google Scholar 

  42. Lowe GC, Onajin O, Baum CL, Otley CC, Arpey CJ, Roenigk RK, Brewer JD. A comparison of Mohs micrographic surgery and wide local excision for treatment of dermatofibrosarcoma protuberans with long-term follow-up: the mayo clinic experience. Dermatol Surg. 2017;43(1):98–106.

    Article  PubMed  CAS  Google Scholar 

  43. Trofymenko O, Bordeaux JS, Zeitouni NC. Survival in patients with primary dermatofibrosarcoma protuberans: National Cancer Database analysis. J Am Acad Dermatol. 2018;78(6):1125–34.

    Article  PubMed  Google Scholar 

  44. Guadagnolo NA, Zagars GK, Araujo D, et al. Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp. Head Neck. 2011;33(5):661–7.

    Article  PubMed  Google Scholar 

  45. Shustef E, Kazlouskaya V, Prieto VG, et al. Cutaneous angiosarcoma: a current update. J Clin Pathol. 2017;70(11):917–25.

    Article  PubMed  CAS  Google Scholar 

  46. Stein JM, Hrabovsky S, Schuller DE, et al. Mohs micrographic surgery and the otolaryngologist. Am J Otolaryngol. 2004;25(6):385–93.

    Article  PubMed  Google Scholar 

  47. Haber R, Battistella M, Pages C, et al. Sebaceous carcinomas of the skin: 24 cases and a literature review. Acta Derm Venereol. 2017;97(8):959–61.

    Article  PubMed  Google Scholar 

  48. Ad Hoc Task Force, Connolly SM, Baker DR, Coldiron BM, et al. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. J Am Acad Dermatol. 2012;67:531–50.

    Article  Google Scholar 

  49. Kyllo RL, Brady KL, Hurst EA. Sebaceous carcinoma: review of the literature. Dermatol Surg. 2015;41(1):1–15.

    Article  PubMed  CAS  Google Scholar 

  50. Bae JM, Choi YY, Kim H, et al. Mohs micrographic surgery for extramammary Paget disease: a pooled analysis of individual patient data. J Am Acad Dermatol. 2013;68(4):632–7.

    Article  PubMed  Google Scholar 

  51. Kyriazanos ID, Stamos NP, Miliadis L, Noussis G, Stoidis CN. Extra-mammary Paget’s disease of the perianal region: a review of the literature emphasizing the operative management technique. Surg Oncol. 2011;20:e61–71.

    Article  PubMed  Google Scholar 

  52. Rismiller K, Knackstedt TJ. Aggressive digital papillary adenocarcinoma: population-based analysis of incidence, demographics, treatment, and outcomes. Dermatol Surg. 2018;44(7):911–7.

    Article  PubMed  CAS  Google Scholar 

  53. Duke WH, Sherrod TT, Lupton GP. Aggressive digital papillary adenocarcinoma (aggressive digital papillary adenoma and adenocarcinoma revisited). Am J Surg Pathol. 2000;24:775–84.

    Article  PubMed  CAS  Google Scholar 

  54. Haynes D, Thompson C, Leitenberger J, Vetto J. Mohs micrographic surgery as a digit-sparing treatment for aggressive digital papillary adenocarcinoma. Dermatol Surg. 2017;43:1487–9.

    Article  PubMed  CAS  Google Scholar 

  55. Knackstedt RW, Knackstedt TJ, Findley AB, Piliang M, et al. Aggressive digital papillary adenocarcinoma: treatment with Mohs micrographic surgery and an update of the literature. Int J Dermatol. 2017;56:1061–4.

    Article  PubMed  Google Scholar 

  56. Goon PKC, Gurung P, Levell NJ, et al. Eccrine porocarcinoma of the skin is rising in incidence in the east of England. Acta Derm Venereol. 2018;98(10):991–2.

    Article  PubMed  Google Scholar 

  57. Nazemi A, Higgins S, Swift R, et al. Eccrine porocarcinoma: new insights and a systematic review of the literature. Dermatol Surg. 2018;44(10):1247–61.

    Article  PubMed  CAS  Google Scholar 

  58. Song SS, Wu Lee W, Hamman MS, et al. Mohs micrographic surgery for eccrine porocarcinoma: an update and review of the literature. Dermatol Surg. 2015;41(3):301–6.

    Article  PubMed  CAS  Google Scholar 

  59. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol. 2002;47(1):1–17.

    Article  PubMed  Google Scholar 

  60. Brin L, Zubair AS, Brewer JD. Optimal management of skin cancer in immunosuppressed patients. Clin Dermatol. 2014;15(4):339–56.

    Google Scholar 

  61. Chen AC, Martin AJ, Choy B, et al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med. 2015;373:1618–26.

    Article  PubMed  CAS  Google Scholar 

  62. Euvrard S, Morelon E, Rostaing L, et al. Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med. 2012;367(4):329–39.

    Article  PubMed  CAS  Google Scholar 

  63. Garrett GL, Blanc PD, Boscardin J, et al. Incidence of and risk factors for skin cancer in organ transplant recipients in the United States. JAMA Dermatol. 2017;153(3):296–303.

    Article  PubMed  Google Scholar 

  64. Harwood CA, Leedham-Green M, Leigh IM, et al. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study. Arch Dermatol. 2005;141(4):456–64.

    Article  PubMed  CAS  Google Scholar 

  65. Jennings L, Schmults CD. Management of high-risk cutaneous squamous cell carcinoma. Am J Clin Aesthet Dermatol. 2010;3(4):39–48.

    Google Scholar 

  66. Mulcahy A, Mulligan SP, Shumack SP. Recommendations for skin cancer monitoring for patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2018;59(3):578–82.

    Article  PubMed  Google Scholar 

  67. Onajin O, Brewer JD. Skin cancer in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma. Clin Adv Hematol Oncol. 2012;10:571–6.

    PubMed  Google Scholar 

  68. Otley CC, Stasko T, Tope WD, et al. Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects. Dermatol Surg. 2006;32(4):562–8.

    PubMed  CAS  Google Scholar 

  69. Ulrich C, Kanitakis J, Stockfleth E, et al. Skin cancer in organ transplant recipients--where do we stand today? Am J Transplant. 2008;8(11):2192–8.

    Article  PubMed  CAS  Google Scholar 

  70. Zwald FO, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol. 2011;65(2):253–61.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Iowa Health Care, Iowa City, IA, USA

    Patricia Richey & Nkanyezi Ferguson

Authors
  1. Patricia Richey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nkanyezi Ferguson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nkanyezi Ferguson .

Editor information

Editors and Affiliations

  1. Department of Dermatology, University of Iowa Health Care, Iowa, IA, USA

    Vincent Liu

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Richey, P., Ferguson, N. (2021). Surgical Approach to Cutaneous Malignancy with Systemic Implications. In: Liu, V. (eds) Dermato-Oncology Study Guide. Springer, Cham. https://doi.org/10.1007/978-3-030-53437-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-53437-0_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-53436-3

  • Online ISBN: 978-3-030-53437-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation